fda compounding semaglutide crackdown november 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounded Semaglutide & Tirzepatide 2025:

The new research, published Monday (Nov

Then I discovered LERCEA Multifunctional Oral Ampoules a plant-based formula with GLP-1 and NAD designed to naturally support circulation, strengthen veins, and reduce swelling from the inside out

Store in the original packaging Don't freeze it (keep away from the freezer) Protect from direct light Avoid the fridge door (temperature swings) Keep away from kids and pets If it freezes: don't use it contact us for a replacement

People with obesity or diabetes can have low vitamin B12 (especially if they take metformin, a common diabetes drug)

Semaglutide-related nausea is mild to moderate, follows a predictable 3-7 day peak after each dose, improves with meal adjustments and anti-nausea medications, and resolves within 8-12 weeks of treatment